05
July
2016
|
16:18
Europe/London

European cancer scientists converge on Manchester to share latest research

Cancer+research

Cancer experts from around Europe will converge on Manchester this weekend (July 9-12) to share expertise with the city’s world-leading scientists at a special Congress.

Organisers say Manchester was chosen to host the European Association for Cancer Research because it is a global centre of excellence for cancer research.

The Congress, which forms part of Manchester City of Science, will see experts share work spanning from basic research to precision medicine – where treatments can be tailored towards individual patients’ differing tumours.

Scientists from Cancer Research UK Manchester Institute and The University of Manchester will be amongst those showcasing their work.

European Association for Cancer Research President Professor Richard Marais, who is also Director of Cancer Research UK Manchester Institute, based at The University of Manchester, said the Congress was an important event for the city.

Professor Marais said: “Manchester is a city of medical and healthcare pioneers and today provides an environment where innovation can grow and prosper.

“It is a hub for top global pharmaceutical, medtech and biotech companies – there are 250 life sciences companies in the region, as well as four universities with a strong track record of working with industry.

“This Congress features an exciting scientific programme, with world-class speakers covering all of the most innovative current research topics from basic research into the biology and understanding of cancer right through to precision medicine.

“This is an emerging important concept in cancer research and treatment today and one of the key focuses of the Manchester Cancer Research Centre,- a partnership between Cancer Research UK, The University of Manchester and The Christie NHS Foundation Trust.

“Researchers here in Manchester and from all over Europe will be able to share their latest work and make new contacts and collaborations that will support important cancer research work in the future.”

The Congress will open with a speech from Sir Harpal Kumar, Cancer Research UK’s chief executive who suggests the best way to predict the future is to invent it.

Manchester has been chosen as European City of Science for 2016 – testament to its important scientific heritage. The Congress will take place at Manchester Central on 9-12 July.

Cancer is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet.

Share this release

Latest news